2013 News Release Archive

 
12/16/2013
Researchers discover how a protein complex revs up T cell activation to fight infections

St. Jude Children’s Research Hospital scientists find mechanism that launches production of the specialized T cells essential for combating infectious agents and that offers new therapeutic possibilities. (Dr. Hongbo Chi)

 
 
12/09/2013
Gene sequencing project finds family of drugs with promise for treating childhood tumor

St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project study identifies drugs that enhance oxidative stress as possible weapon against most common pediatric soft tissue tumor. (Dr. Michael Dyer)

 
 
12/03/2013
Gene therapy bolsters enzyme activity to combat Alzheimer’s disease in mice

St. Jude Children’s Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer’s disease and related disorders. (Dr. Alessandra d'Azzo)

 
 
12/02/2013
1950s pandemic influenza virus remains a health threat, particularly to those under 50

St. Jude Children’s Research Hospital scientists report that avian H2N2 influenza A viruses related to 1957-1958 pandemic infect human cells and spread among ferrets; may aid identification of emerging threats. (Dr. Robert Webster)

 
 
11/18/2013
Adult survivors of childhood cancer at risk of becoming frail at an early age

St. Jude Children’s Research Hospital study finds that young adults who had cancer as children are more likely to be frail than their peers; this condition leaves survivors at increased risk of death and chronic disease. (Dr. Kirsten Ness)

 
 
11/15/2013
Drug offers promising approach to improve outcome for children with high-risk leukemia

St. Jude Children’s Research Hospital leads study showing that a drug withdrawn from the market in 2010 may enhance the effectiveness of bone marrow transplants for select pediatric leukemia patients. (Dr. Jeffrey Rubnitz)

 
 
10/21/2013
St. Jude Children’s Research Hospital scientific director elected to Institute of Medicine

James R. Downing, M.D., becomes hospital’s sixth IOM member

 
 
10/20/2013
Inherited gene variation tied to high-risk pediatric leukemia and greater risk of relapse

Study led by St. Jude Children’s Research Hospital finds an inherited gene variation—more common among Hispanic Americans–is tied to increased risk of developing a high-risk form of pediatric leukemia. (Dr. Jun Yang)

 
 
10/20/2013
Research offers new insight in quest for single vaccine against multiple influenza strains

A study led by St. Jude Children’s Research Hospital identifies new path to a universal influenza vaccine emphasizing production of broadly specific antibodies that target multiple flu viruses. (Dr. Maureen McGargill)

 
 
10/10/2013
Preventable risk factors pose serious threat to heart health of childhood cancer survivors

A Childhood Cancer Survivors Study led by St. Jude Children’s Research Hospital suggests that reducing risk factors like hypertension might lower the risk of heart disease for survivors as they age. (Dr. Greg Armstrong)

 
 
10/10/2013
St. Jude Children’s Research Hospital names new chief legal officer

Robyn Diaz, J.D., tapped to serve as chief legal officer and senior vice president.

 
 
10/09/2013
St. Jude Children’s Research Hospital scientist recognized by American-Italian Cancer Foundation

Charles J. Sherr, M.D., Ph.D., to receive the Prize for Scientific Excellence in Medicine by the American-Italian Cancer Foundation.

 
 
09/26/2013
St. Jude Children’s Research Hospital appoints new clinical director

Larry Kun, M.D., to oversee all aspects of patient care and clinical services at the hospital.

 
 
09/16/2013
Immune system marker tied to improved bone marrow transplant outcomes

St. Jude Children’s Research Hospital investigators prove that an immune marker predicts transplant success and improves selection of bone marrow donors (Dr. Wing Leung)

 
 
09/16/2013
St. Jude Children’s Research Hospital CEO announces retirement

Dr. William E. Evans will retire from executive post in July 2014.

 
 
09/09/2013
Rare, inherited mutation leaves children susceptible to acute lymphoblastic leukemia

Research from St. Jude Children’s Research Hospital, Memorial Sloan-Kettering Cancer Center and the University of Washington identifies a mutation that predisposes individuals to most common form of childhood leukemia. (Dr. Charles Mullighan)

 
 
09/02/2013
Drug reduces hospitalizations and cost of treating young children with sickle cell anemia

The St. Jude Children’s Research Hospital-led national BABY HUG trial linked hydroxyurea to a 21 percent reduction in annual medical costs for young children with sickle cell anemia; savings expected to grow. (Dr. Winfred Wang)

 
 
09/02/2013
St. Jude Children’s Research Hospital recognizes Childhood Cancer Awareness Month

At St. Jude, doctors and scientists work to improve childhood cancer survival rates as well as enhance patients’ long-term quality of life after treatment.

 
 
08/29/2013
St. Jude Children’s Research Hospital study yields new strategy against high-risk leukemia

After identifying a protein that blocks death of high-risk acute lymphoblastic leukemia (ALL) cells, scientists use two-drug combination therapy to offer hope to children and adults with the disease. (Dr. Joseph Opferman)

 
 
08/28/2013
St. Jude Children’s Research Hospital scientists identify ALS disease mechanism

Study strengthens link between amyotrophic lateral sclerosis (ALS) and problems in protein production machinery of cells and identifies possible treatment strategy. (Dr. J. Paul Taylor)

 
 
08/08/2013
Understanding mutation leads to promising new treatment for autoinflammatory diseases

St. Jude Children’s Research Hospital study yields clues for designing next-generation drugs to treat autoinflammatory diseases. (Dr. Kanneganti)

 
 
08/04/2013
Mechanism offers promising new approach for harnessing the immune system to fight cancer

St. Jude Children’s Research Hospital researchers discover how to unleash the immune system against cancer in model system without triggering autoimmune reactions. (Dr. Dario Vignali)

 
 
08/02/2013
St. Jude creates $5.5 million endowment for cancer research to be held by the hospital CEO

The Donald Pinkel Endowed Chair of Pediatric Cancer Treatment honors first director of St. Jude and is among the largest endowed chairs in the nation.

 
 
07/10/2013
Protein targeted for cancer drug development is essential for normal heart function

St. Jude Children’s Research Hospital discovers a role for a protein in research that has implications for treatment of cancer and heart disease. (Dr. Joseph Opferman)

 
 
07/03/2013
Maintaining immune balance involves an unconventional mechanism of T cell regulation

St. Jude Children’s Research Hospital study challenges prior understanding of the process regulating specialized T cells that are essential for a balanced immune system. (Dr. Hongbo Chi)

 
 
06/13/2013
St. Jude Children’s Research Hospital postdoctoral fellow named Pew Latin American Fellow

Andres Herrada, Ph.D., a postdoctoral fellow in the Department of Immunology at St. Jude Children’s Research Hospital, has been named a Pew Latin American Fellow in the Biomedical Sciences by The Pew Charitable Trusts.

 
 
06/11/2013
Childhood cancer survivors found to have significant undiagnosed disease as adults

St. Jude Children’s Research Hospital study identifies the need for proactive, life-long medical follow-up and provides the most complete health picture yet of adult survivors of childhood cancer. (Dr. Melissa Hudson)

 
 
06/10/2013
Epigenetic factor likely plays a key role in fueling most common childhood cancer

A study led by St. Jude Children’s Research Hospital shows epigenetic changes that turn genes on and off are as unique as alterations in DNA and may be as important in causing the most common childhood cancer. (Dr. Charles Mullighan)

 
 
05/29/2013
James Hoffman, Pharm.D., named American Society of Health-System Pharmacists fellow

James M. Hoffman, Pharm.D., medication outcomes and safety officer at St. Jude Children’s Research Hospital, has been named a fellow by the American Society of Health-System Pharmacists (ASHP) for excellence in pharmacy practice.

 
 
05/14/2013
Robert Webster, Ph.D., presented with National Foundation for Infectious Diseases award

Virologist Robert G. Webster, Ph.D., of St. Jude Children’s Research Hospital, is the recipient of the Charles Mérieux Award from the National Foundation for Infectious Diseases (NFID).

 
 
05/13/2013
St. Jude ranked No. 1 preferred company to work for by millennials

St. Jude Children’s Research Hospital ranks first on the list of places top students and young professionals want to work, according to a survey conducted by the National Society of High School Scholars (NSHSS).

 
 
05/09/2013
St. Jude scientist named Howard Hughes Medical Institute investigator

Michael Dyer, Ph.D., of St. Jude Children's Research Hospital, has been recognized as one of the nation’s leading biomedical researchers by the Howard Hughes Medical Institute.

 
 
04/30/2013
T cells rely on “rheostat” to help ensure that the immune response matches the threat

St. Jude Children’s Research Hospital advances understanding of how T cells craft an appropriate immune response; setting the stage for new strategies to intervene if the system goes awry. (Dr. Dario Vignali)

 
 
04/26/2013
Charles Sherr, M.D., Ph.D., recognized as 2013 fellow of the American Academy of Arts and Sciences

St. Jude Children’s Research Hospital scientist named to honorary society.

 
 
04/15/2013
Butterfly release to mark second annual Ependymoma Awareness Day

St. Jude Children’s Research Hospital and the CERN Foundation host event to bring attention to a rare brain tumor that strikes both children and adults

 
 
04/14/2013
Gene sequencing project finds new mutations to blame for a majority of brain tumor subtype

The St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies. (Dr. David Ellison)

 
 
03/27/2013
St. Jude scientist named American Association for Cancer Research Academy Fellow

Charles Sherr, M.D., Ph.D., of St. Jude Children’s Research Hospital, is honored by the AACR Academy for his scientific contributions to advancing understanding and treatment of cancer.

 
 
03/21/2013
Cancer drug shortages mean higher costs and greater risk for patients

St. Jude Children’s Research Hospital plays key role in research showing that drug shortages erode the quality and increase the cost of cancer care; experts warn that shortages persist despite efforts to fix the problem. (Dr. James Hoffman)

 
 
03/19/2013
St. Jude Children’s Research Hospital announces issuance of U.S. patent for genetically modified human immune cells for cancer therapy

The United States Patent and Trademark Office today awarded St. Jude Children’s Research Hospital U.S. patent number 8,399,645 for St. Jude’s invention of compositions for genetically modifying human immune cells so they can destroy some of the most common forms of cancer in children and adults.

 
 
03/19/2013
Inherited genetic variations have a major impact on childhood leukemia risk

Study links inherited genetic variations in a few genes to increased risk of acute lymphoblastic leukemia (ALL) and helps to explain ethnic differences in the cancer’s incidence. (Dr. Jun J. Yang)

 
 
03/03/2013
Two new genes linked to amyotrophic lateral sclerosis (ALS) and related disorders

St. Jude Children’s Research Hospital ties mutations in two genes to the death of motor neurons associated with ALS, or Lou Gehrig's disease, and other devastating neurodegenerative problems. (J. Paul Taylor, MD, PhD)

 
 
02/15/2013
Rise in drug costs to hospitals, clinics slowing in 2013

St. Jude Children’s Research Hospital-led analysis finds rise less than in previous years; cancer drugs the exception. (James Hoffman, PharmD)

 
 
02/04/2013
St. Jude Children’s Research Hospital named as a top cancer care hospital by national magazine survey

St. Jude Children’s Research Hospital has been named one of the best cancer care hospitals in the country by Parents magazine. The results, based on the magazine’s survey of more than 60 children’s hospitals, appear in the March 2013 issue.

 
 
01/24/2013
Gene sequencing project mines data once considered 'junk' for clues about cancer

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project takes new approach to measuring the repetitive DNA at the end of chromosomes and opens new window on mechanisms fueling cancer. (Jinghui Zhang, PhD)

 
 
01/20/2013
Genetic basis of high-risk childhood cancer points to possible new drug treatment strategy

St. Jude Children’s Research Hospital scientists lead a study that finds new genetic defects in high-risk childhood leukemia subtypes with chromosomal loss and evidence that some patients have an inherited cancer syndrome. (Charles Mullighan, MBBS(Hons), MSc, MD)

 
 
01/16/2013
St. Jude Children’s Research Hospital on FORTUNE magazine’s “100 Best Companies to Work For” list for third year

St. Jude Children’s Research Hospital has been recognized for the third consecutive year by FORTUNE magazine as one of the “100 Best Companies to Work For.”